These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38911661)

  • 21. Myeloid spatial and transcriptional molecular signature of ischemia-reperfusion injury in human liver transplantation.
    Sosa RA; Ahn R; Li F; Terry AQ; Qian Z; Bhat A; Sen S; Naini BV; Ito T; Kaldas FM; Hoffmann A; Busuttil RW; Kupiec-Weglinski JW; Gjertson DW; Reed EF
    Hepatol Commun; 2024 Jan; 8(1):. PubMed ID: 38206205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early allograft dysfunction after liver transplantation: a definition and predictors of outcome. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
    Deschênes M; Belle SH; Krom RA; Zetterman RK; Lake JR
    Transplantation; 1998 Aug; 66(3):302-10. PubMed ID: 9721797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Donor Hepatic Occult Collagen Deposition Predisposes to Peritransplant Stress and Impacts Human Liver Transplantation.
    Hirao H; Ito T; Kadono K; Kojima H; Naini BV; Nakamura K; Kageyama S; Busuttil RW; Kupiec-Weglinski JW; Kaldas FM
    Hepatology; 2021 Nov; 74(5):2759-2773. PubMed ID: 34170562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Native macrophages genetically modified to express heme oxygenase 1 protect rat liver transplants from ischemia/reperfusion injury.
    Shen XD; Ke B; Uchida Y; Ji H; Gao F; Zhai Y; Busuttil RW; Kupiec-Weglinski JW
    Liver Transpl; 2011 Feb; 17(2):201-10. PubMed ID: 21280193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreasing Significance of Early Allograft Dysfunction with Rising Use of Nonconventional Donors.
    Ohara S; Macdonough E; Egbert L; Brooks A; Lizaola-Mayo B; Mathur AK; Aqel B; Reddy KS; Jadlowiec CC
    Medicina (Kaunas); 2022 Jun; 58(6):. PubMed ID: 35744084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute cellular rejection is associated with matrix metalloproteinase-2 genotype chimerism after orthotopic liver transplantation.
    Korkmaz KS; Ten Hove WR; de Rooij BJ; van Hoek B; van der Reijden JJ; Coenraad MJ; Dubbeld J; Verspaget HW
    Transplant Proc; 2013 Mar; 45(2):558-63. PubMed ID: 23498792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model.
    Agopian VG; Harlander-Locke MP; Markovic D; Dumronggittigule W; Xia V; Kaldas FM; Zarrinpar A; Yersiz H; Farmer DG; Hiatt JR; Busuttil RW
    JAMA Surg; 2018 May; 153(5):436-444. PubMed ID: 29261831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Rifaximin Therapy on Ischemia/Reperfusion Injury in Liver Transplantation: A Propensity Score-Matched Analysis.
    Ito T; Nakamura K; Kageyama S; Korayem IM; Hirao H; Kadono K; Aziz J; Younan S; DiNorcia J; Agopian VG; Yersiz H; Farmer DG; Busuttil RW; Kupiec-Weglinski JW; Kaldas FM
    Liver Transpl; 2019 Dec; 25(12):1778-1789. PubMed ID: 31509643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early Allograft Dysfunction After Liver Transplantation Is Associated With Short- and Long-Term Kidney Function Impairment.
    Wadei HM; Lee DD; Croome KP; Mai ML; Golan E; Brotman R; Keaveny AP; Taner CB
    Am J Transplant; 2016 Mar; 16(3):850-9. PubMed ID: 26663518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of Early Allograft Dysfunction in Adult Live Donor Liver Transplantation: The A2ALL Experience.
    Pomposelli JJ; Goodrich NP; Emond JC; Humar A; Baker TB; Grant DR; Fisher RA; Roberts JP; Olthoff KM; Gillespie BW; Merion RM
    Transplantation; 2016 Jul; 100(7):1490-9. PubMed ID: 27326811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicenter validation of the liver graft assessment following transplantation (L-GrAFT) score for assessment of early allograft dysfunction.
    Agopian VG; Markovic D; Klintmalm GB; Saracino G; Chapman WC; Vachharajani N; Florman SS; Tabrizian P; Haydel B; Nasralla D; Friend PJ; Boteon YL; Ploeg R; Harlander-Locke MP; Xia V; DiNorcia J; Kaldas FM; Yersiz H; Farmer DG; Busuttil RW
    J Hepatol; 2021 Apr; 74(4):881-892. PubMed ID: 32976864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant relaxin protects liver transplants from ischemia damage by hepatocyte glucocorticoid receptor: From bench-to-bedside.
    Kageyama S; Nakamura K; Fujii T; Ke B; Sosa RA; Reed EF; Datta N; Zarrinpar A; Busuttil RW; Kupiec-Weglinski JW
    Hepatology; 2018 Jul; 68(1):258-273. PubMed ID: 29350771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome-wide DNA methylation and transcriptomic analysis of liver tissues subjected to early ischemia/reperfusion injury upon human liver transplantation.
    Giraudi PJ; Laraño AA; Monego SD; Pravisani R; Bonazza D; Gondolesi G; Tiribelli C; Baralle F; Baccarani U; Licastro D
    Ann Hepatol; 2024; 29(4):101506. PubMed ID: 38710471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized-controlled trial of ischemia-free liver transplantation for end-stage liver disease.
    Guo Z; Zhao Q; Jia Z; Huang C; Wang D; Ju W; Zhang J; Yang L; Huang S; Chen M; Zhu X; Hu A; Ma Y; Wu L; Chen Y; Han M; Tang Y; Wang G; Wang L; Li L; Xiong W; Zhang Z; Shen Y; Tang Z; Zhu C; Chen X; Hu X; Guo Y; Chen H; Ma Y; Zhang T; Huang S; Zeng P; Lai S; Wang T; Chen Z; Gong J; Yu J; Sun C; Li C; Tan H; Liu Y; Dong Y; Sun C; Liao B; Ren J; Zhou Z; Andrea S; Björn N; Cai C; Gong F; Rong J; Huang W; Guan X; Clavien PA; Stefan TG; Huang J; He X
    J Hepatol; 2023 Aug; 79(2):394-402. PubMed ID: 37086919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heme Oxygenase-1 in liver transplant ischemia-reperfusion injury: From bench-to-bedside.
    Hirao H; Dery KJ; Kageyama S; Nakamura K; Kupiec-Weglinski JW
    Free Radic Biol Med; 2020 Sep; 157():75-82. PubMed ID: 32084514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic effect of ischemia-reperfusion injury upon primary graft dysfunction and chronic lung allograft dysfunction in lung transplantation: evidence based on transcriptome data.
    Zheng XY; Huang H; Wei ZT; Yan HJ; Wang XW; Xu L; Li CH; Tang HT; Wang JJ; Yu ZW; Tian D
    Transpl Immunol; 2022 Apr; 71():101556. PubMed ID: 35202801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early Allograft Dysfunction After Live Donor Liver Transplantation: It's Time to Redefine?
    Pamecha V; Pattnaik B; Sinha PK; Patil NS; Sasturkar SV; Mohapatra N; Kumar G; Choudhury A; Sarin SK
    J Clin Exp Hepatol; 2022; 12(1):101-109. PubMed ID: 35068790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolomics discloses donor liver biomarkers associated with early allograft dysfunction.
    Cortes M; Pareja E; García-Cañaveras JC; Donato MT; Montero S; Mir J; Castell JV; Lahoz A
    J Hepatol; 2014 Sep; 61(3):564-74. PubMed ID: 24798621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Donor information based prediction of early allograft dysfunction and outcome in liver transplantation.
    Hoyer DP; Paul A; Gallinat A; Molmenti EP; Reinhardt R; Minor T; Saner FH; Canbay A; Treckmann JW; Sotiropoulos GC; Mathé Z
    Liver Int; 2015 Jan; 35(1):156-63. PubMed ID: 24351095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Donor Hepatic Steatosis on Ischemia Reperfusion Injury in Liver Transplant Recipient.
    Jadhav PV; Kothakota SR; Sasidharan M; Kareem H; Nair AK
    J Clin Exp Hepatol; 2020; 10(3):236-244. PubMed ID: 32405180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.